Clinical Trial Update: AXONE-Acute II: Acute Assessment of a Micro Multipolar Lead for Enhanced Cardiac Resynchronisation Therapy [NA]

View source ↗

Summary

Clinical trial AXONE-Acute II reports the completed assessment of a micro multipolar lead designed to enhance Cardiac Resynchronisation Therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Snippet

Sponsor: University Hospital, Rouen | Conditions: Cardiac Resynchronisation Therapy | NA | Status: COMPLETED